share_log

奥赛康:关于子公司注射用福沙匹坦双葡甲胺获得药品注册证书的公告

Beijing Aosaikang Pharmaceutical: Announcement regarding subsidiary's pharmaceutical registration certificate for injection of Fosaprepitant Dimeglumine.

SZSI ·  Jul 2, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more